GR3000689T3 - Methods for treating gout with chalcone derivatives - Google Patents

Methods for treating gout with chalcone derivatives

Info

Publication number
GR3000689T3
GR3000689T3 GR90400536T GR900400536T GR3000689T3 GR 3000689 T3 GR3000689 T3 GR 3000689T3 GR 90400536 T GR90400536 T GR 90400536T GR 900400536 T GR900400536 T GR 900400536T GR 3000689 T3 GR3000689 T3 GR 3000689T3
Authority
GR
Greece
Prior art keywords
chalcone derivatives
methods
treating gout
inhibit
reported
Prior art date
Application number
GR90400536T
Other languages
English (en)
Inventor
Michael L Edwards
David M Stemerick
Sai P Sunkara
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of GR3000689T3 publication Critical patent/GR3000689T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/45Monoamines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Saccharide Compounds (AREA)
GR90400536T 1987-04-09 1990-08-02 Methods for treating gout with chalcone derivatives GR3000689T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3621487A 1987-04-09 1987-04-09

Publications (1)

Publication Number Publication Date
GR3000689T3 true GR3000689T3 (en) 1991-09-27

Family

ID=21887305

Family Applications (1)

Application Number Title Priority Date Filing Date
GR90400536T GR3000689T3 (en) 1987-04-09 1990-08-02 Methods for treating gout with chalcone derivatives

Country Status (10)

Country Link
EP (1) EP0287901B1 (el)
KR (1) KR880012529A (el)
AT (1) ATE55108T1 (el)
AU (1) AU608821B2 (el)
DE (1) DE3860376D1 (el)
ES (1) ES2016865B3 (el)
GR (1) GR3000689T3 (el)
IE (1) IE60734B1 (el)
PH (1) PH24634A (el)
ZA (1) ZA882388B (el)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54152091A (en) * 1978-05-22 1979-11-29 Fuji Photo Film Co Ltd Photopolymerizable composition
US4279930A (en) * 1978-10-10 1981-07-21 The Upjohn Company Process for treating inflammation
NZ192641A (en) * 1979-01-26 1984-10-19 Hoffmann La Roche Substituted acetophenones and pharmaceutical compositions
CA1168659A (fr) * 1980-08-06 1984-06-05 Gerard Lang Derives de dibenzoylmethane quaternaire, leur utilisation comme agent filtrant solaire et composition cosmetique les contenant

Also Published As

Publication number Publication date
IE881076L (en) 1988-10-09
ZA882388B (en) 1988-09-22
KR880012529A (ko) 1988-11-28
PH24634A (en) 1990-08-17
AU1416588A (en) 1988-10-13
EP0287901B1 (en) 1990-08-01
DE3860376D1 (de) 1990-09-06
ES2016865B3 (es) 1990-12-01
EP0287901A1 (en) 1988-10-26
IE60734B1 (en) 1994-08-10
AU608821B2 (en) 1991-04-18
ATE55108T1 (de) 1990-08-15

Similar Documents

Publication Publication Date Title
PH25183A (en) Controlling the growth of certain tumor tissue with chalcone derivatives
ES2059420T3 (es) Metodo de tratamiento de esclerosis multiples con derivados chalcona.
ATE94069T1 (de) Verwendung von physiologisch wirksamen substanzen zur herstellung von medikamenten fuer gehirn- und nervenerkrankungen.
DE3876052D1 (de) Medizinische verwendung.
CA2098849A1 (en) Control of gene expression by ionizing radiation
ATE345092T1 (de) Apparat zur therapeutischen elektromagnetischen strahlen therapie von der haut
AU6760987A (en) Method of treating alzheimer's disease
DE3854656D1 (de) Depotimplantat mit gesteuerter Wirkstoffabgabe zur Behandlung von Krankheiten des Nervensystems.
FI852626A0 (fi) Menetelmä ihmisen tuumorinekroositekijän valmistamiseksi ja sitä koodaava DNA
DE69731540D1 (de) Behandlung von diarrhoe
CA2068281A1 (en) Tumor treatment
EP0237082A3 (en) Transglutaminase inhibitors
DE3888274D1 (de) Vorrichtung zur intensiven und kontrollierten Herstellung von Mikroorganismen durch Photosynthese.
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
ATE282425T1 (de) Verfahren zur behandlung von endothelialen verletzungen
DE69331605D1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
ZA886459B (en) Use of bezafibrate for treating diabetes
GR3000689T3 (en) Methods for treating gout with chalcone derivatives
DE68916266D1 (de) Methode zur Herstellung und Stabilisierung von Halosilanen mit Acrylfunktionen.
ATE222491T1 (de) Melatonin-derivate zur verwendung in der behandlung von schlafstörungen
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
ATE108331T1 (de) Verwendung von tnf zur herstellung eines arzneimittels zur behandlung von psoriasis.
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
ATE139696T1 (de) Verwendung von benzothiazepinen zur herstellung von arzneimitteln zur behandlung von epileptischen anfällen
Doyle Pilot plant investigation of the biological phosphorus removal process